Olivier Harismendy
Cited by
Cited by
Evaluation of next generation sequencing platforms for population targeted sequencing studies
O Harismendy, PC Ng, RL Strausberg, X Wang, TB Stockwell, KY Beeson, ...
Genome biology 10 (3), R32, 2009
9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response
O Harismendy, D Notani, X Song, NG Rahim, B Tanasa, N Heintzman, ...
Nature 470 (7333), 264-268, 2011
Microdroplet-based PCR enrichment for large-scale targeted sequencing
R Tewhey, JB Warner, M Nakano, B Libby, M Medkova, PH David, ...
Nature biotechnology 27 (11), 1025, 2009
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling
G He, D Dhar, H Nakagawa, J Font-Burgada, H Ogata, Y Jiang, ...
Cell 155 (2), 384-396, 2013
Genome‐wide location of yeast RNA polymerase III transcription machinery
O Harismendy, CG Gendrel, P Soularue, X Gidrol, A Sentenac, M Werner, ...
The EMBO journal 22 (18), 4738-4747, 2003
General repression of RNA polymerase III transcription is triggered by protein phosphatase type 2A-mediated dephosphorylation of Maf1
D Oficjalska-Pham, O Harismendy, WJ Smagowicz, AG de Peredo, ...
Molecular cell 22 (5), 623-632, 2006
Enrichment of sequencing targets from the human genome by solution hybridization
R Tewhey, M Nakano, X Wang, C Pabón-Peña, B Novak, A Giuffre, E Lin, ...
Genome biology 10 (10), R116, 2009
Method for improving sequence coverage uniformity of targeted genomic intervals amplified by LR-PCR using Illumina GA sequencing-by-synthesis technology
O Harismendy, KA Frazer
Biotechniques 46 (3), 229-231, 2009
Accurate detection and genotyping of SNPs utilizing population sequencing data
V Bansal, O Harismendy, R Tewhey, SS Murray, NJ Schork, EJ Topol, ...
Genome research 20 (4), 537-545, 2010
A covering method for detecting genetic associations between rare variants and common phenotypes
G Bhatia, V Bansal, O Harismendy, NJ Schork, EJ Topol, K Frazer, ...
PLoS computational biology 6 (10), 2010
Biomarkers of endocannabinoid system activation in severe obesity
JC Sipe, TM Scott, S Murray, O Harismendy, GM Simon, BF Cravatt, ...
PloS one 5 (1), 2010
Use of liquid biopsies in clinical oncology: pilot experience in 168 patients
M Schwaederle, H Husain, PT Fanta, DE Piccioni, S Kesari, RB Schwab, ...
Clinical cancer research 22 (22), 5497-5505, 2016
Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens
SE Yost, EN Smith, RB Schwab, L Bao, HC Jung, X Wang, E Voest, ...
Nucleic acids research 40 (14), e107-e107, 2012
Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing
O Harismendy, RB Schwab, L Bao, J Olson, S Rozenzhak, ...
Genome biology 12 (12), R124, 2011
Maf1 is involved in coupling carbon metabolism to RNA polymerase III transcription
M Cieśla, J Towpik, D Graczyk, D Oficjalska-Pham, O Harismendy, ...
Molecular and cellular biology 27 (21), 7693-7702, 2007
FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors
E Shi, J Chmielecki, CM Tang, K Wang, MC Heinrich, G Kang, CL Corless, ...
Journal of translational medicine 14 (1), 339, 2016
Sensitive gene fusion detection using ambiguously mapping RNA-Seq read pairs
M Kinsella, O Harismendy, M Nakano, KA Frazer, V Bafna
Bioinformatics 27 (8), 1068-1075, 2011
iPSCORE: a resource of 222 iPSC lines enabling functional characterization of genetic variation across a variety of cell types
AD Panopoulos, M D'Antonio, P Benaglio, R Williams, SI Hashem, ...
Stem cell reports 8 (4), 1086-1100, 2017
Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin
H Alakus, ML Babicky, P Ghosh, S Yost, K Jepsen, Y Dai, A Arias, ...
Genome medicine 6 (5), 43, 2014
Deep mining heterogeneous networks of biomedical linked data to predict novel drug–target associations
N Zong, H Kim, V Ngo, O Harismendy
Bioinformatics 33 (15), 2337-2344, 2017
The system can't perform the operation now. Try again later.
Articles 1–20